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Abstract: In the present study, we investigated the
regulation of chemokine-mediated responses and re-
ceptor expression on eosinophils from mice. MIP-1
(CCL3) and eotaxin (CCL11) induced a significant
and only partially overlapping intracellular calcium
flux in antigen-elicited and peripheral blood eosino-
phils, and MCP-1 (CCL2), MDC (CCL22), MIP-1
(CCL4), and TCA-3 (CCL1) did not. To demonstrate
functional use of the specific receptors, we examined
chemotactic responses. Peripheral blood eosinophils
migrated toward MIP-1 (CCL3) and eotaxin
(CCL11) but not MCP-1 (CCL2), MDC (CCL22),
MIP-1 (CCL4), and TCA-3 (CCL1). Antigen-elicited
eosinophils migrated toward MIP-1 (CCL3) and
eotaxin (CCL11), but also migrated in response to
MIP-1 (CCL4) and TCA-3 (CCL1), suggesting the
up-regulation of additional chemokine receptors on
antigen-elicited eosinophils. The up-regulation of the
additional chemokine-receptor responses appeared
to be in part because of cytokine activation, because
TNF- and/or IL-4 were able to up-regulate CCR1,
-3, -5, and -8 mRNA expression in eosinophils as well
as migration responses to the appropriate ligands.
Using antibodies specific for CCR5 and CCR8, the
chemotactic response to MIP-1 and TCA-3, respec-
tively, was reduced significantly. Finally, the expres-
sion of these new receptors appears to have an effect
on activation and degranulation because MIP-1
(CCL4) and TCA-3 (CCL1) induce significant levels of
LTC4 from elicited eosinophils. These results suggest
that eosinophils may up-regulate and use additional
chemokine receptors during progression of inflam-
matory, allergic responses for migration and
activation. J. Leukoc. Biol. 71: 1019–1025; 2002.
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INTRODUCTION
Eosinophils play a central role in numerous inflammatory
diseases including allergic disorders, parasitic infections, and
malignancies [1, 2]. When activated, eosinophils are able to
release many mediators such as eosinophil peroxidase, ly-
sozyme, lipid mediators, cytokines, and chemokines. As effec-
tor cells, eosinophils must be activated to be able to carry out
their function. Once activated at a site of inflammation/immune
response, these mediators can alter tissue function significantly
and may lead to long-term pathophysiologic changes. After
appropriate activation, eosinophils have increased expression
of surface receptors involved in eosinophil recruitment and
activation. It is the expression of these chemoattractant recep-
tors that may play a key role in determining the increased
tissue localization and activation during disease.
Chemokines mediate a range of proinflammatory effects on
leukocytes, including chemotaxis, activation, and degranula-
tion [3–5]. Historically, RANTES was the first CC-chemokine
shown to induce eosinophil chemotaxis [6, 7]. In addition to
RANTES, other CC-family chemokine members have been
shown to be potent eosinophil chemoattractants; among them,
eotaxin and monocyte chemoattractant protein (MCP)-4 appear
to be the most effective as a result of their ability to bind to
CCR3 [8–11]. However, other CC-chemokines, such as mac-
rophage-inflammatory protein-1 (MIP-1) and macrophage-
derived chemokine (MDC) that do not bind to CCR3, also
appear to alter eosinophil accumulation in vivo [12–15]. A
family of G-protein-coupled seven-transmembrane receptors
mediate chemokine action on leukocytes [16]. There are 10
known receptors that mediate the actions of CC-chemokines
CCR1–CCR10. The expression of these receptors on different
leukocyte subsets influences their migration and activation at
inflammatory sites. In particular, peripheral eosinophils have
been shown to express high levels of CCR3, and CCR1 is
expressed at much lower levels—only at 1–5% of the level of
CCR3. The expression of other CC-chemokine receptors on
eosinophils is still to be elucidated. The data in the present
study suggest that once eosinophils are activated properly or
recruited to a site of T-helper cell type 2 (Th2)-induced in-
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flammation, additional chemokine receptors are up-regulated




Dr. Fred Lewis at the Biomedical Research Laboratory (Frederick, MD)
supplied Swiss Webster mice, infected heavily with Schistosoma mansoni
helminth parasite. These mice displayed severe infection and very significant
eosinophilia with 50% of circulating granulocytes as eosinophils. The inter-
leukin (IL)-5 transgenic mice were provided by Dr. Sergio Lira (Schering-
Plough, Kenilworth, NJ). Antibodies specific for CCR5 were purchased from
R&D Systems (Rochester, MN), and CCR8-specific monoclonal antibodies
were a gift from Dr. Carlos Martinez (Madrid, Spain).
Antigen-elicited peritoneal eosinophil purification
Eosinophils were elicited by injection of thioglycolate plus soluble egg antigen
(SEA) into the peritoneum of S. mansoni-infected mice or with only thiogly-
colate in IL-5 transgenic mice. SEA was prepared in our laboratory by grinding
isolated eggs from heavily infected S. mansoni-infected mice as described
previously [12]. The injection of SEA into infected mice induces a pool of
circulating eosinophils recruited into the peritoneum in an antigen-specific
manner, whereas thioglycolate in IL-5 transgenic mice elicits cells in a
nonspecific manner. The heavily infected schistosome mice and IL-5 trans-
genic mice have a similar level of circulating eosinophils (50% of granulo-
cytes). Using these two mice, we could elicit eosinophils that were from an
antigen-induced Th2-associated environment or those from a nonspecific in-
flammatory environment that were enhanced for survival. After 48 h, the mice
were lavaged peritoneally, and the cells were collected. The initial population
that is isolated from the peritoneum was 50% eosinophils with only 2–5%
neutrophils and 35–45% mononuclear cells (lymphocytes and macrophages).
Adherent cell populations were removed from the population by plastic ad-
herence in tissue-culture dishes for 1 h. The nonadherent cells were washed
and resuspended in phosphate-buffered saline (PBS)/bovine serum albumin
(BSA; 90 l PBS/BSA per 107 cells), and eosinophils were purified by negative
immunomagnetic bead-coupled antibodies to exclude contaminating immune
cells using the magnetic cell-sorter (MACS) system. The antibodies used were
anti-Thy1 (for T cells), anti-B220 (for B cells), and anti-class II (for antigen-
presenting cells). After the plate adherence and MACS separation, the popu-
lation of cells contained 97% eosinophils with contaminating neutrophils
(1%) and mononuclear cells (1–2%).
Blood peripheral eosinophil
Eosinophils were purified from peripheral blood from S. mansoni-infected mice
using Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden). Erythrocytes were
removed by hypotonic lysis. Routinely, 50% of the granulocytes were eosin-
ophils. These cell populations were used only for chemotaxis; they could not be
purified further because unlike human cells, there is no specific antibody for
mouse neutrophils, and they could not be separated further by density gradi-
ents. However, they were stained differentially in chemotaxis assays to indicate
the enumeration of only eosinophils that migrated to a specific stimulus.
Measurement [Ca] intracellular
Peritoneal-elicited eosinophils purified by immunomagnetic negative selection
and peripheral blood eosinophil purified by Ficoll were suspended in 5 ml
Hanks’ balanced saline solution/0.1% BSA containing 2.5 M Fura-2-AM and
incubated at 37°C for 30 min. Measurement of changes in intracellular calcium
from eosinophils was described previously [17]. Calculation of intracellular-
free calcium was derived from the fluorescence spectra (excitation wave-
lengths, 340 and 380 nm; emission wavelengths, 510 nm) in accordance with
established methods.
Eosinophil chemotaxis assay
Chemotaxis assay was based on the methods described previously [13]. Eo-
sinophils were suspended at 3  106 cells/ml in Dulbecco’s PBS plus 0.5%
BSA and were placed in the top wells of the microchemotaxis chamber. Bottom
wells were filled with CC-chemokines (R&D Systems) in the following con-
centrations: eotaxin, MIP-1, MIP-1, and trichloroacetic acid (TCA)-3 (10
and 100 ng/ml) or assay medium as negative control. Eosinophil migration was
quantified by counting the number of eosinophil migrations completely through
the filter in 10 high-powered fields (HPF) in triplicate samples. The data are
expressed as the average number of countable, adherent cells per HPF (SEM).
The eosinophils were identified using differential staining (Diff-Quik) that
clearly stained the granules eosin red, and the neutrophils and eosinophils
could be delineated clearly and easily. Only eosinophils were counted in these
assays.
Measurement of eosinophil LTC4 release
To analyze LTC4 release from the eosinophils suspended in phenol red-free
Dulbecco’s modified Eagle’s medium containing L-serine (25 mM) to inhibit
mediator degradation [18], cells were allowed to incubate for 4 h with a
particular chemokine. The supernatant from the activated cells (2106 eosin-
ophils) was harvested, and LTC4 release was measured using a specific
enzyme-linked immunosorbent assay (Calbiochem, Ann Arbor, MI). The assay
is sensitive to 1 pg/ml LTC4.
Reverse transcriptase-polymerase chain reaction
(RT-PCR) analysis
Total cellular RNA was extracted from 3  106 eosinophils using TRIzol
reagent (Life Techonologies, Invitrogen Corp., Carlsbad, CA), and RT-PCR
was conducted using standard methodology. Sequences of the primers for the
amplification were: CCR1 (sense 5	-gaccagcatctacctgttca-3	 and antisense
5	-gcagaaacaaatacactcag-3	); CCR2 (sense 5	-cacgaagtatccaagagc-3	 and an-
tisense 5	-catgctcttcagctttttac-3	); CCR3 (sense 5	-tgggcaacatgatggttgtg-3	 and
antisense 5	-gctgtcttgagactcatgga-3	); CCR4 (sense 5	-cctgcctcctctctactcct-3	
and antisense 5	-acgtgtggttgtgctctgtg-3	); CCR5 (sense 5	-gctgaagagcgtgact-
gata-3	 and antisense 5	-gaggactgcatgtataatga-3	); CCR8 (sense 5	-gagcatca-
cagatatctacct-3	 and antisense 5	-ctcaaagactgctcttcat-3	). The PCR mixture
was incubated in a thermocycler using the following temperature profile:
denaturation step at 94°C for 4 min followed by 35 cycles (CCR1, CCR4,
CCR5, and CCR8) and 30 cycles (CCR2 and CCR3) of denaturation at 94°C
for 45 s, annealing at 55°C for 45 s, and extension at 72°C for 45 s. The final
extension step was 72°C for 10 min. PCR samples were run on a 2% agarose
gel stained with 10 mg/ml ethidium bromide, and the PCR products were
visualized with UV light and were photographed.
Statistics
Data were analyzed by analysis of variance, and significance was determined
with P values 
 0.05.
RESULTS
Calcium flux responses are similar between
peripheral and elicited eosinophils
A rapid, transient calcium flux is observed typically when
leukocytes are stimulated with chemokine, and it serves as a
convenient measure of chemokine-receptor activation. To in-
vestigate the signaling properties of chemokine receptors
present in mouse eosinophils, we determined the ability of
particular CC-chemokines specific for certain receptors to in-
crease intracellular Ca. Activation of isolated, antigen-elic-
ited eosinophils (see Materials and Methods) with MIP-1
(Fig. 1A) and eotaxin (Fig. 1B) induced a significant elevation
in the intracellular calcium level in these cells. Eotaxin and
MIP-1 desensitized the calcium response to themselves (data
not shown), but only partially to one another, suggesting bind-
ing to shared and unshared receptors (Fig. 1, C and D). MCP-1,
MDC, thymus and activation-regulated chemokine (TARC),
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MIP-1, or TCA-3, specific ligands for CCR2, CCR4, CCR5,
and CCR8, did not increase the intracellular Ca level in
these cells (data not shown) nor did any of these latter chemo-
kines desensitize MIP-1 or eotaxin-induced responses (data
not shown). In peripheral blood eosinophils, eotaxin and
MIP-1 also induced a significant elevation in the intracellular
calcium level, with a similar desensitization profile as elicited
eosinophils, again suggesting that they bind to distinct, un-
shared receptors. MCP-1, TARC, MDC, or MIP-1 failed to
induce a positive response in these cells (data not shown).
These results suggest that antigen elicited and peripheral
eosinophils have similar, functional CC-chemokine receptors.
Similar data have been previously published indicating that
these same CC-chemokines were able to induce changes in
[Ca2] in human eosinophils [19].
Chemokine-induced eosinophil migration is
altered in antigen-elicited eosinophils
To determine the ability of various CC-chemokines to induce
chemotaxis in antigen-elicited versus peripheral blood eosin-
ophils, we then used a classic two-chamber assay. Chemotactic
activity for peripheral blood eosinophils was observed with
MIP-1 and eotaxin, but not MIP-1 and TCA-3 (Fig. 2A).
These results suggest that peripheral blood eosinophils express
functional CCR1 and CCR3 as described previously [20]. In
contrast, antigen-elicited eosinophils migrated toward MIP-1,
eotaxin, MIP-1, and TCA-3 (Fig. 2B). There was no migration
to MCP-1 in peripheral or elicited eosinophils (unpublished
results). These results suggest that antigen-elicited eosinophils
express CCR1, CCR3, CCR5, and CCR8 functionally. It is
interesting that MIP-1 and TCA-3 induced no evidence of
calcium flux in eosinophils, but they appear to have functional
receptors as evidenced by their migration responses.
Characterization of altered eosinophil
responsiveness
The differences in chemotactic responses found in these stud-
ies between peripheral and antigen-elicited eosinophils sug-
gest an increased expression during migration and/or specific
activation of the transmigrated eosinophils. To address the first
question of whether migration alone was responsible for in-
creasing CCR expression, we used IL-5 transgenic mice. Eo-
sinophils were elicited in a nonspecific manner using thiogly-
colate. Thus, low levels of immune-specific cytokines, such as
IL-4 (
10 pg/ml), were produced at the site of elicitation. The
comparison of eosinophil chemotaxis in these studies demon-
strated that the thioglycolate (nonspecific)-elicited eosinophils
from IL-5 trangenic mice responded in the same manner as
peripheral cells (Fig. 3). That is, they migrated only to MIP-1
and eotaxin with no migration toward any concentration of
MIP-1 or TCA-3 (1–100 ng/ml; data not showns). Thus,
elicitation alone did not appear to be enough to up-regulate the
Fig. 1. Elevation of calcium intracellular in eosinophils from S. mansoni-infected mice induced by MIP-1 and eotaxin (EOT). Antigen-elicited eosinophils were
loaded with Fura-2 and exposed to MIP-1 (A, C, and D, 30 ng/ml) and eotaxin (B–D, 30 ng/ml). Changes in fluorescence after activation were monitored using
a fluorimeter. Results are representative of at least three experiments.
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additional chemokine responses. Cytokines, such as tumor
necrosis factor  (TNF-) and IL-4, have been shown to
contribute to the regulation of eosinophil activation in vivo and
in vitro [21–23]. The method used to elicit the eosinophils in S.
mansoni-infected mice includes using specific schistosoma
SEA. This antigen induces significant levels of inflammatory
and Th2-type cytokines, especially TNF- and IL-4 [24]. In
our experiments synchronous activation of eosinophils from
IL-5 transgenic animals with TNF- or IL-4 were able to
up-regulate CCR1, CCR3, CCR5, and CCR8 mRNA expres-
sion 6 h after cytokine stimulation in vitro (Fig. 4). The
migratory responses of the elicited eosinophils were also ex-
amined after incubation with IL-4 or TNF- (Fig. 5). The
migration to MIP-1, eotaxin, and MIP-1 was increased
significantly after overnight incubation with TNF- or IL-4.
However, although CCR8 mRNA was up-regulated by TNF-
and IL-4, the chemotactic responses to TCA-3 were increased
with TNF but decreased after IL-4. This latter observation will
be examined further in future experiments. Taken together,
these data suggest that TNF- and IL-4 are able to up-regulate
CC-chemokine receptor mRNA expression and are represen-
tative factors that are involved in facilitating increased chemo-
kine-mediated migratory responses in eosinophils.
To determine whether increased MIP-1 and TCA-3 che-
motactic activity was induced by CCR5 and CCR8, respec-
tively, antigen (SEA)-elicited eosinophils from schistosome-
infected mice were treated with antichemokine receptor anti-
bodies for 15 min before subjecting them to chemotactic
analysis. The data in Figure 6 illustrates that the antireceptor
antibodies blocked the chemotactic responses to their respec-
tive ligands significantly. It is interesting that chemotaxis to
MIP-1 was not altered by the anti-CCR8 antibody treatment
but was altered slightly by the anti-CCR5 treatment. These
latter data suggest that at least part of the response to MIP-1
may be a result of CCR5 expression in antigen-elicited eosin-
ophils. In separate experiments, eotaxin-induced chemotaxis
was inhibited by anti-CCR3, but was not altered by anti-CCR5
or anti-CCR8 treatment (data not shown). Thus, these data
verify that blocking specific chemokine receptors inhibits
movement to the appropriate ligands.
Chemokine-mediated LTC4 release
Chemokines not only participate in leukocyte migration, but
also induce degranulation and activation of effector cell pop-
Fig. 2. Chemotactic activity of MIP-1, eotaxin, MIP-1, and TCA-3 on peripheral blood eosinophils (A) and antigen-elicited eosinophils (B). Cells (3106/ml)
were subjected to chemotaxis in a Boyden chamber, and the number of cells that migrated through the membrane was counted. The results represent the mean 
SEM of duplicate cultures with 10 HPF counted in each. Similar data were obtained in four other experiments (*, P
0.001 when compared with control).
Fig. 3. Elicited eosinophils from IL-5 transgenic mice do not migrate to
MIP-1 or TCA-3. Transgenic mice overexpressing IL-5 were injected intra-
peritoneally with thioglycolate to elicit the peripheral eosinophils nonspecifi-
cally. The isolated eosinophils were then subjected to eosinophil chemotaxis
assays to chemokine levels that induced peak responses previously in Figure
2 (MIP-1, 10 ng/ml; eotaxin, 100 ng/ml; MIP-1, 100 ng/ml; and TCA-3, 10
ng/ml). The results represent the mean  SEM of duplicate cultures with 10
HPF counted in each. Similar data were obtained in three other experiments (*,
P
0.001 when compared with control).
Fig. 4. Incubation of elicited eosino-
phils (Eos) from IL-5 transgenic animals
with TNF- (20 ng/ml) or IL-4 (20 ng/
ml) for 6 h up-regulates CCR1, CCR3,
CCR5, and CCR8 mRNA expression.
Total mRNA (4 g) purified from 3 
106 cells was used in RT-PCR analysis.
Data are representative of results re-
peated in three separate experiments.
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ulations. The ability of MIP-1 and TCA-3 to induce eosino-
phil degranulation and activation was assessed using in vitro
cultures of elicited eosinophils from the S. mansoni-infected
mice. Eosinophils were stimulated for 4 h in culture with
various levels of the chemokines, and the supernatants were
assessed for levels of LTC4 (Fig. 7). The data in Figure 7
suggest that eotaxin, MIP-1, TCA-3, and MIP-1 induce
significant LTC4 release and appear to be as effective as
eotaxin and MIP-1. These results are intriguing considering
their differential signaling as observed with Ca flux above.
Thus, the ability of elicited and cytokine-stimulated eosino-
phils to respond to additional chemokines may have the sig-
nificant relevance for eosinophil activation and degranulation
at the site of the response.
DISCUSSION
The presence of specific receptors CCR1 and CCR3 has been
described previously in peripheral blood eosinophils from IL-5
transgenic mice [20], in eosinophilic cell lines [25], and in
human peripheral eosinophils [26]. In the present studies, the
Fig. 5. Preincubation of elicited eosinophils with
IL-4 or TNF- increases migratory function of the
cells. Eosinophils elicited in schistosome-infected
mice were incubated overnight with or without
TNF- or IL-4 (20 ng/ml). After washing in fresh
media, eosinophils were subjected to chemotactic
assays with MIP-1 (10 ng/ml), eotaxin (100 ng/
ml), MIP-1 (100 ng/ml), and TCA-3 (10 ng/ml).
Data represent mean  SEM of three repeats for
each group. *, P 
 0.05.
Fig. 6. Inhibition of MIP-1 and TCA-3-mediated chemotaxis by anti-CCR5 and anti-CCR8, respectively. Antigen-elicited eosinophils were treated with 10 g
anti-CCR5 or anti-CCR8 antibody for 15 min on ice. Subsequently, the eosinophils were subjected to chemotactic analysis as described. Data represent mean 
SEM from two repeat studies. TCA-3 and MIP-1 were assessed with different sets of eosinophils and therefore, have their own controls. Background eosinophil
numbers ranged from 17 to 35 eosinophils/HPF (1000 original magnification).
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increased reactivity to additional chemokines that do not bind
CCR1 and CCR3 suggests that a broader profile of chemokines
may be relevant for tissue eosinophilia in allergic disease
progression. The expression of CCR5 and CCR8 on eosinophils
appeared to depend on the activation state of the cells. Periph-
eral eosinophils or elicited eosinophils from IL-5 transgenic
mice (which were not elicited by an antigen-specific response)
displayed no evidence of MIP-1 or TCA-3-mediated re-
sponses. However, cytokine activation was a primary stimulus
that could induce the de novo expression of the specific recep-
tors CCR5 and CCR8 and increased migration to their specific
ligands MIP-1 and TCA-3. Eosinophils elicited to a site of a
Th2-type immune reaction in heavily infected S. mansoni mice
displayed responses to the CCR5 and CCR8 ligands, MIP-1,
and TCA-3. These interactions were verified by blocking the
CCR5 and CCR8 specifically during functional chemotactic
responses, respectively. Thus, the immune environment ap-
pears to regulate the chemokine receptor display and chemo-
kine responsiveness with eosinophils.
The dissociation of calcium flux response from chemotactic
activity observed with peritoneal-elicited eosinophils has also
been observed in T cells and human eosinophils, where che-
motactic responses could be observed without detectable cal-
cium mobilization [15, 27]. Although they represent two dif-
ferent parameters to analyze receptor function, the activation
pathways between Ca flux and chemotaxis or degranulation
may be different. One possible explanation may be that differ-
ent subunits of the G-protein signaling pathway are involved,
with the  subunit inducing Ca flux and / subunits
together responsible for chemotaxis [28–31]. Alternatively,
chemokine receptors can couple non-Gi protein pathways [32,
33]. Functionally, the up-regulation of additional chemokine
receptors in eosinophils that have migrated into inflamed tissue
may have significant contributions to additional eosinophil
functions, including migration, activation, and degranulation
during disease. In fact, the expression of these new receptors
appears to have a significant role in activation and degranula-
tion of the eosinophils for LTC4 generation and release. These
findings may serve as an important model, whereby one set of
chemokines, such as eotaxin and MIP-1, may be a primary
stimulus for eosinophil migration, and other chemokines may
be responsible for eosinophil activation and degranulation at
the site of the immune response. Although the role of chemo-
kines in asthma is not yet completely understood, multiple
chemokines and their receptors appear to participate in eosin-
ophil migration and activation during allergic airways disease
[7, 34–37]. Therefore, understanding which chemokine recep-
tors are being expressed during eosinophil activation will be an
important approach for targeting therapy to prevent the migra-
tion and activation of eosinophils in allergic disease.
Many chemokines have now been shown to cause degranu-
lation and release of multiple mediators from eosinophils [4,
38–40]. In these studies, the up-regulation of CCR5 and CCR8
by cytokines, such as IL-4 and TNF-, suggests that these
receptors are most highly expressed after the eosinophil mi-
grates into the inflamed tissues. This is supported by the data
using elicited eosinophils from IL-5 transgenic mice that were
not exposed to antigen-induced immune cytokines and did not
migrate to MIP-1 or TCA-3. The receptors could only be
detected in eosinophils from IL-5 transgenic mice after IL-4
and TNF- stimulation. This regulation of chemokine-receptor
expression likely occurs on multiple leukocyte populations
during immune responses and may function to regulate leuko-
cyte movement and activation into the inflamed environment. It
is interesting that a recent study from our laboratory has
indicated that CCR8 / mice have a deficit in eosinophils
recruited to the airway during allergen or parasitic responses
[41]. In those earlier studies, no CCR8 was evident on periph-
eral eosinophils, but no attempt was made at examining re-
cruited eosinophils. Thus, the lack of CCR8 expression on
activated and recruited eosinophils in those studies may have
had an impact on the inflammatory response.
In conclusion, elicited eosinophils from antigen-specific re-
sponses express receptors for multiple CC-chemokines that
appear to be up-regulated by at least IL-4 and TNF-. It may
be important for eosinophils to use multiple chemokines as
they move from vessel to inflamed tissue in order to be acti-
vated optimally and/or regulated. Furthermore, the data sug-
gest that the environment and the activation state of eosino-
phils likely contribute to chemokine-receptor expression. That
eosinophils may use additional receptor-mediated responses
for eosinophil activation once they have migrated into tissue
allows a greater ability to regulate their function. This would
have a significant impact in patients with allergic disorders and
may influence the determination of therapeutic targets for
disease research.
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Fig. 7. Activation of eosinophils by MIP-1 and TCA-3. Isolated eosinophils
from mice infected heavily with S. mansoni were subjected to activation with
eotaxin, MIP-1, MIP-1, or TCA-3 (100 ng/ml). Culture supernatants were
harvested at 4 h post-activation and assayed for LTC4 levels. Data represent
mean  SE of three repeat activations. *, P 
 0.05.
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